Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; Gland Pharma has informed that the ESOP Compensation Committee of the Board of Directors of the Company has allotted 332,450 Equity shares of Rs 1 each of the Company, fully paid up, on July 5, 2021 to employees on exercise of their Stock Options pursuant to Gland Pharma Employee Stock Options Scheme, 2019. Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to Rs 164,237,173 comprising of 164,237,173 Equity shares of face value Rs1 each.
The above information is a part of company’s filings submitted to BSE.
